Premaitha Health has signed two new service contracts with customers in Armenia and Moldova for its IONA test – the non-invasive prenatal screening test (NIPT) for Down’s Syndrome on pregnant women.
The company has already signed distribution deals for IONA to laboratories in France and Greece.
Premaitha chief executive Dr Stephen Little said: “We are pleased to see our international footprint increase as demand for NIPT using the IONA test grows. The high clinical standards and excellent customer support offered by Premaitha’s screening services team, coupled with the proven performance of the IONA test means that we are able to provide pregnant women with the best possible screening test.”
See the article in full at TheBusinessDesk.com